Maintaining a regular hemoglobin level can be achieved by using regular ESA doses combined with intravenous iron doses adapted to S-ferritin (SF) and transferrin saturation (TSAT) thresholds that are lower than those used in routine practice; this contributes to a reduced risk of iron overload [60]. This evidence concerns the gene TF and Tangier disease.